Houlihan Capital advised the owners of HCVA on its partnership with US Heart & Vascular (“USHV”), an Ares company
December 2021 Houston Cardiovascular Associates, P.A. Sale to Ares Management Sector: Healthcare Services Houlihan Capital (Chicago, IL) acted as exclusive financial advisor on the sale of Houston Cardiovascular Associates, P.A., a physician-owned cardiology practice, to Los Angeles, California-based asset management company, Ares Management. Headquartered inside the world-renowned Texas Medical Center in Houston, TX, Houston Cardiovascular […]
Houlihan Capital advised the owners of Renal Specialists of Houston on its partnership with Panoramic Health, an Audax company
March 2022 Renal Specialists of Houston, P.A. Sale to Panoramic Health Sector: Healthcare Houlihan Capital acted as exclusive financial advisor on the sale of Renal Specialists of Houston, P.A. (“RSOH”), a leading kidney wellness specialist group, to Tempe, Arizona-based Panoramic Health. Headquartered in Houston, RSOH specializes in a diverse set of services, including inpatient and […]
SPACs – Proposed New Rules by the SEC
The SEC recently proposed new rules and amendments intended to enhance investor protections in initial public offerings by special purpose acquisition companies (“SPACs”) and in subsequent business combination transactions between SPACs and private operating companies. If adopted, the rules would impact SPACs in a variety of important ways. Below we summarize and comment upon the […]
Houlihan Capital Advised on the Recapitalization of DocMJ by Chatham Capital
Houlihan Capital’s Investment Banking Group is pleased to announce the following transaction: October 2021 Recapitalization of DocMJ Debt & Equity Provided by Chatham Capital Sector: Ancillary Services – Cannabis Houlihan Capital acted as the exclusive financial advisor to DocMJ, the leading group of medical marijuana doctors in the state of Florida, on its recapitalization through […]
Monica Blocker discusses Possible Amendments to Investment Advisers Act of 1940 with EisnerAmper
Monica Blocker, Director – Business Development, recently sat down with EisnerAmper to discuss possible amendments to the Investment Advisers Act of 1940 and shared her insights on valuation. As of May 9, 2022, the SEC reopened the comment period for the proposed rules. To read the discussion, please click here. Houlihan Capital is here to […]